Enzalutamide May Represent Novel Therapeutic Option for Triple-Negative Breast Cancer

Enzalutamide May Represent Novel Therapeutic Option for Triple-Negative Breast Cancer

Enzalutamide may be a viable alternative therapy over cytotoxic chemotherapy for individuals with triple-negative breast cancer, according to a study presented at the 2015 American Society of Clinical Oncology annual meeting.

Persistent HPV16 in Oral Rinses Signals Poor Prognosis for HPV-Positive Oropharyngeal Carcinoma

Persistent HPV16 in Oral Rinses Signals Poor Prognosis for HPV-Positive Oropharyngeal Carcinoma

Detection of human papillomavirus (HPV)16 DNA in oral rinses following treatment for HPV-positive oropharyngeal carcinoma could be a potential tool for long-term tumor surveillance, a study concluded at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

Elective Neck Dissection Recommended Standard of Care for Early Oral Cancer

Elective Neck Dissection Recommended Standard of Care for Early Oral Cancer

Elective neck dissection in clinically node-negative early oral squamous cell carcinoma should be considered the standard of care.

Radiosurgery and Careful Monitoring Combo Recommended for Newly Diagnosed Brain Metastases

Radiosurgery and Careful Monitoring Combo Recommended for Newly Diagnosed Brain Metastases

Radiosurgery and close monitoring is recommended to better preserve cognitive function in newly diagnosed brain metastases.

Adapting Pediatric Cancer Treatments to Spur Early Detection and Reduce Late Effects

Adapting Pediatric Cancer Treatments to Spur Early Detection and Reduce Late Effects

Modifying pediatric cancer treatments may reduce occurrence of late effects and promoting early detection, indicated data from a 5-year analysis of childhood cancers survivors presented at ASCO 2015.

Nivolumab Yields Better Clinical Outcomes for Advanced Melanoma

Nivolumab Yields Better Clinical Outcomes for Advanced Melanoma

Treatment-naïve patients with advanced melanoma had significantly better clinical outcomes with nivolumab alone or in combination with ipilimumab.

PET-CT Surveillance Cost-Effective for Locally Advanced Head and Neck Squamous Cell Cancer

PET-CT Surveillance Cost-Effective for Locally Advanced Head and Neck Squamous Cell Cancer

PET-CT guided active surveillance for patients with locally advanced head and neck squamous cell cancer is an option over node dissection, per analysis data presented at the 2015 American Society of Clinical Oncology annual meeting.

Pembrolizumab Active in Advanced Gastric Cancer

Pembrolizumab Active in Advanced Gastric Cancer

The anti-PD-1 monoclonal antibody, pembrolizumab (MK-3475), demonstrated promising antitumor activity in advanced gastric cancer, according to a study presented at the 2015 ASCO Annual Meeting.

Aspirin Exposure after Colorectal Cancer Diagnosis Associated with Improved Survival

Aspirin Exposure after Colorectal Cancer Diagnosis Associated with Improved Survival

Aspirin exposure after a colorectal cancer diagnosis was independently associated with improved colorectal cancer-specific survival.

Addition of SIRT Fails to Improve Overall Progression-free Survival in Colorectal Cancer Liver Metastases

Addition of SIRT Fails to Improve Overall Progression-free Survival in Colorectal Cancer Liver Metastases

Addition of selective internal radiation therapy (SIRT) failed to improve progression-free survival in non-resectable colorectal cancer liver metastases.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs